Chapter 10: Calcium, phosphate, parathyroid hormone, bicarbonate and total cholesterol concentrations amongst patients receiving haemodialysis or peritoneal dialysis in England, Wales and Northern Ireland in 2009: National and centre-specific analyses

Nephron - Clinical Practice

Volumn 119, Issue SUPPL. 2, 2011, Pages

  Castledine, Clare ^a   Van Schalkwyk, Dirk ^a   Feest, Terry ^a   Steenkamp, Retha ^a   Dawnay, Anne ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bicarbonate; Biochemical variables; Calcium; Cholesterol; Dialysis; Haemodialysis; Parathyroid hormone; Peritoneal dialysis; Phosphate; Quality improvement

Indexed keywords

BICARBONATE; CALCIUM PHOSPHATE; CHOLESTEROL; PARATHYROID HORMONE; BIOLOGICAL MARKER; CALCIUM; PHOSPHATE;

ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MEDICAL AUDIT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; UNITED KINGDOM; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEALTH CARE MANAGEMENT; LONGITUDINAL STUDY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; REGISTER; RENAL REPLACEMENT THERAPY; STANDARD;

AMBULATORY CARE FACILITIES; ANNUAL REPORTS AS TOPIC; BICARBONATES; BIOLOGICAL MARKERS; CALCIUM; CHOLESTEROL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENGLAND; HUMANS; LONGITUDINAL STUDIES; NORTHERN IRELAND; PARATHYROID HORMONE; PERITONEAL DIALYSIS; PHOSPHATES; REGISTRIES; RENAL DIALYSIS; WALES;

EID: 80052493194     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000331778     Document Type: Article

References (18)

1. Renal association. Clinical practice guidelines. 4th edition. Module 2 complications. http://www.Renal.Org/clinical/oldguidelines.Aspx
2. Ansell D, Feehally J, Feest T, Tomson C, Williams AJ, Warwick G: U.K. Renal registry report 2007. Chapter 9. Management of biochemical variables. UK Renal Registry, Bristol, UK 2007
3. Ansell D, Tomson CRV: Chapter 15 uk renal registry annual report: U.K. Renal registry, ukrr database, validation and methodology. Nephron Clin Pract 2009;111 Suppl 1:c277-c285.Epub 2009 Mar 26
4. Morton AR, Garland JS, Holden RM: Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial;23:283-289
5. KDOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. http://www.kidney.org/professionals/KDOQI/guidelines- bone/index.htm
6. Spiegelhalter DJ: Funnel plots for comparing institutional performance. Statistics in Medicine 2005;24:1185-1202 (Pubitemid 40485757)
7. Renal association. Clinical practice guidelines. 5th edition, 2010. http:// www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx
8. Labriola L,Wallemacq P, Gulbis B, Jadoul M: The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations. Nephrology Dialysis Transplantation 2009;24:1834-1838
9. Clase CM, Norman GL, Beecroft ML, Churchill DN: Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrology Dialysis Transplantation 2000;15:1841-1846
10. Gauci C,Moranne O, Fouqueray B, de la Faille R, Maruani G, Haymann J-P, Jacquot C, Boffa J-J, Flamant M, Rossert J, Urena P, Stengel B, Souberbielle J-C, Froissart M, Houillier P, NephroTest Study G: Pitfalls of measuring total blood calcium in patients with ckd. Journal of the American Society of Nephrology 2008;19:1592-1598
11. Clase CM, St Pierre MW, Churchill DN: Conversion between bromcresol green and bromcresol purple measured albumin in renal disease. Nephrology Dialysis Transplantation 2001;16:1925-1929 (Pubitemid 32821429)
12. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780 (Pubitemid 44215354)
13. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and pth and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 2006;70:351-357 (Pubitemid 44086585)
14. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT: The kidney disease outcomes quality initiative (k/doqi) guideline for bone metabolism and disease in ckd: Association with mortality in dialysis patients. Am J Kidney Dis 2005;46:925-932 (Pubitemid 41505468)
15. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004;15:770-779 (Pubitemid 38294808)
16. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218 (Pubitemid 39031360)
17. Danese MD, Belozeroff V, Smirnakis K, Rothman KJ: Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008;2:2
18. Ansell DF, T.G. (eds): Renal registry 7th annual report. In chapter 6: Adequacy of haemodialysis and serum bicarbonate, 2004, pp 59-86